Rheumatoid arthritis

Single-cell resolution of longitudinal blood transcriptome profiles in rheumatoid arthritis, systemic lupus erythematosus and healthy control pregnancies

Ann Rheum DisPublished Longitudinal transcriptomic cohort study

Authors' conclusion

We found distinct RA, SLE and pregnancy signatures, and no expression patterns could be attributed to medication or disease activity.

Study context

Population
Women with Rheumatoid arthritis (RA), systemic lupus erythematosus (SLE) and healthy controls sampled before pregnancy, at each trimester, and 6 weeks, 6 months and 12 months post partum335 whole blood samples
Participants
84 women
Exposure
RA vs SLE vs healthy pregnancies
Outcome
Cellular composition and peripheral blood gene expression
Methodological detailsbulk and single-cell RNA analyses, flow cytometry validation, cell-type adjusted analysis
  • Bulk and single-cell RNA analyses
  • Flow cytometry validation
  • Cell-type adjusted analysis

Main finding

As reported in the abstract

  • SLE: interferon signature augmented during pregnancy; pregnancy signature continued post partum
  • Altered cell type composition strongly influences the profile
  • Pregnancy signature: transcripts involved in galactosylation, potentially altering autoantibody effector functions, became more evident
  • Several genes in the adjusted RA signature are expressed in mucosal associated invariant T cells

Observational data: associations, not effects.

Further findings

Disease control and pregnancy complications

Patients well regulated throughout pregnancy; few had pregnancy complications

Original publication

Single-cell resolution of longitudinal blood transcriptome profiles in rheumatoid arthritis, systemic lupus erythematosus and healthy control pregnancies. Ann Rheum Dis. Published 15 February 2024. doi:10.1136/ard-2023-224644

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.